谭耀红, 杨纯正, 齐静, 王金宏, 王彩云, 彭辉. 3-取代芳基氧化吲哚(PH II-7)对肿瘤细胞周期的影响J. 药学学报, 2003, 38(11): 802-808.
引用本文: 谭耀红, 杨纯正, 齐静, 王金宏, 王彩云, 彭辉. 3-取代芳基氧化吲哚(PH II-7)对肿瘤细胞周期的影响J. 药学学报, 2003, 38(11): 802-808.
TAN Yao-hong, YANG Chun-zheng, QI Jing, WANG Jin-hong, WANG Cai-yun, PENG Hui. Effects of 3-substituted aryl oxindole(PH II-7) on cell cycle of tumor cellsJ. Acta Pharmaceutica Sinica, 2003, 38(11): 802-808.
Citation: TAN Yao-hong, YANG Chun-zheng, QI Jing, WANG Jin-hong, WANG Cai-yun, PENG Hui. Effects of 3-substituted aryl oxindole(PH II-7) on cell cycle of tumor cellsJ. Acta Pharmaceutica Sinica, 2003, 38(11): 802-808.

3-取代芳基氧化吲哚(PH II-7)对肿瘤细胞周期的影响

Effects of 3-substituted aryl oxindole(PH II-7) on cell cycle of tumor cells

  • 摘要: 目的观察3-取代芳基氧化吲哚(PH II-7)对肿瘤细胞周期分布的影响,明确PH II-7的抗敏感肿瘤和耐药肿瘤的共同机制。方法用流式细胞仪检测细胞周期分布,Western印迹分析细胞周期相关蛋白的表达,3H-TdR参入法检测细胞DNA合成,ELISA测定酪氨酸激酶的活性。结果PH II-7对多种肿瘤细胞(包括耐药细胞)的周期分布均有影响,阻滞细胞G1期至S期的移行,细胞周期相关蛋白CDK2,Rb和c-myc的表达被抑制,Cyclin E的表达升高。PH II-7还可抑制3H-TdR的参入,抑制EGFR的酪氨酸激酶的活性。结论抗耐药肿瘤新药PH II-7是一种细胞周期阻滞剂,可能是通过抑制CDK2而使肿瘤细胞阻滞在G1期,同时也说明细胞周期阻滞可能是抗耐药肿瘤的新方向。

     

    Abstract: AimTo study the antitumor mechanism of 3-substituted aryl oxindole (PH II-7) and determine its effects on cell cycle distribution of tumor cells. MethodsThe cell cycle distributions were determined with FACS. The cell cycle regulation-related proteins of K562 lysates were analyzed with Western Blot. The inhibition of PH II-7 on DNA synthesis of tumor cells were estimated though 3H-thymidine incorporation and the tyrosine kinase activity of EGFR of A431 lysates was measured with ELISA. ResultsPH II-7 effected cell cycle distribution of several tumor cells, including multidrug resistant tumor cell lines, and accumulation of cells in the G0-G1 stages was observed. The cell cycle regulation-related proteins CDK2, Rb and c-myc were inhibited by PH II-7 in a dose dependent manner, whereas the expression of CyclinE was increased after exposure to PH II-7. Furthermore, PH II-7 2.0 mg·L-1 was shown to inhibit the incorporation of 3H-thymidine into DNA, and 21.89%-41.29% of the PTK activity of EGFR in A431 lysates was inhibited by PH II-7 2-8 mg·L-1 in a dose-dependant manner. ConclusionPH II-7, a new anti-tumor agent, blocks the transition of cell cycle of tumor cells from G1 to S phase by inhibition CDK2.

     

/

返回文章
返回